Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Jacquet

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer|August 1, 2022
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancerDavide Soldato, Julie Havas, Tracy E Crane, et al.
Cancer Research|March 9, 2021
Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα InhibitorsYanyan Cai, Guotai Xu, Fan Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcomeAlice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
JAMA Network Open|September 23, 2022
Contraceptive Use in Premenopausal Women With Early Breast CancerMatteo Lambertini, Claudia Massarotti, Julie Havas, et al.
Nature|July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature|May 24, 2019
Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Journal of the National Cancer Institute|July 12, 2023
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuationFélix Balazard, Aurélie Bertaut, Élise Bordet, et al.
Nature Medicine|January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trialThomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.
Nature|September 7, 2022
Genomics to select treatment for patients with metastatic breast cancerFabrice Andre, Thomas Filleron, Maud Kamal, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer|August 1, 2022
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancerDavide Soldato, Julie Havas, Tracy E Crane, et al.
Cancer Research|March 9, 2021
Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα InhibitorsYanyan Cai, Guotai Xu, Fan Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcomeAlice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
JAMA Network Open|September 23, 2022
Contraceptive Use in Premenopausal Women With Early Breast CancerMatteo Lambertini, Claudia Massarotti, Julie Havas, et al.
Nature|July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature|May 24, 2019
Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Journal of the National Cancer Institute|July 12, 2023
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuationFélix Balazard, Aurélie Bertaut, Élise Bordet, et al.
Nature Medicine|January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trialThomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.
Nature|September 7, 2022
Genomics to select treatment for patients with metastatic breast cancerFabrice Andre, Thomas Filleron, Maud Kamal, et al.
Pageof 2